Published by Frank Prenesti on 1st July 2022
(Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
URL: http://www.digitallook.com/dl/news/story/32791133/...